Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Organovo Holdings Inc Logo

ARKG Holdings of Organovo (ONVO) - Updated Daily

Key Statistics

DateAugust 05, 2022Revenue
Expected$6.55m
Actualโ–ซ๏ธ
EPS
Expected
Actualโ–ซ๏ธ
๐Ÿ•ต๐ŸผFound In๐ŸทLast Price
ARKGARKQ$3.18
โš–๏ธWeighting๐ŸงขMarket Cap
0.02%$27.70m
๐Ÿ‹๐Ÿฟโ€โ™‚๏ธWeight Rank In ARKG๐ŸงฎPrice to Sales
4618.47
๐Ÿ‹๏ธโ€โ™€๏ธWeight Rank Across All Funds๐ŸŒCountry
220๐Ÿ‡บ๐Ÿ‡ธUnited States
๐Ÿ’ณARK Estimated Cost Average๐ŸŽซARK Ownership Percent
$58.102.25%
Description
Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's proprietary technology is being used to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Organovo's advances include cell type-specific compartments, prevalent intercellular tight junctions, and the formation of microvascular structures. Management believes these attributes can enable critical complex, multicellular disease models that can be used to develop clinically effective drugs for selected therapeutic areas.
Website
www.organovo.com

Research Notes and Commentary for ONVO

No Research Notes Found for ONVO